Genesis IBRC India [GENESIS] vs Zota Health Care [ZOTA] Detailed Stock Comparison
Genesis IBRC India
BSE
Loading...
Zota Health Care
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Genesis IBRC India wins in 9 metrics, Zota Health Care wins in 8 metrics, with 0 ties. Genesis IBRC India appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Genesis IBRC India | Zota Health Care | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 29.47 | -74.47 | Zota Health Care |
| Price-to-Book Ratio | 10.23 | 19.30 | Genesis IBRC India |
| Debt-to-Equity Ratio | 0.00 | 0.61 | Genesis IBRC India |
| PEG Ratio | 1.03 | -29.79 | Zota Health Care |
| EV/EBITDA | 29.57 | -1,139.61 | Zota Health Care |
| Profit Margin (TTM) | 94.96% | -17.04% | Genesis IBRC India |
| Operating Margin (TTM) | 94.96% | -10.35% | Genesis IBRC India |
| EBITDA Margin (TTM) | 94.96% | N/A | N/A |
| Return on Equity | 41.08% | -24.83% | Genesis IBRC India |
| Return on Assets (TTM) | 39.67% | -12.84% | Genesis IBRC India |
| Free Cash Flow (TTM) | $-3,000 | $-959.42M | Genesis IBRC India |
| Dividend Yield | N/A | 0.07% | N/A |
| 1-Year Return | 330.64% | 137.77% | Genesis IBRC India |
| Price-to-Sales Ratio (TTM) | 28.00 | 13.44 | Zota Health Care |
| Enterprise Value | $1.04B | $48.09B | Zota Health Care |
| EV/Revenue Ratio | 28.26 | 16.41 | Zota Health Care |
| Gross Profit Margin (TTM) | N/A | 56.43% | N/A |
| Revenue per Share (TTM) | $3 | $122 | Zota Health Care |
| Earnings per Share (Diluted) | $2.68 | $-20.81 | Genesis IBRC India |
| Beta (Stock Volatility) | 0.54 | 0.49 | Zota Health Care |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Genesis IBRC India vs Zota Health Care Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Genesis IBRC India | 5.00% | 21.53% | 107.62% | 272.20% | 330.64% | 330.64% |
| Zota Health Care | 2.13% | -4.00% | 16.56% | 44.43% | 72.88% | 76.58% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Genesis IBRC India | 330.64% | 330.64% | 907.40% | 907.40% | 907.40% | 907.40% |
| Zota Health Care | 137.77% | 382.52% | 863.38% | 1,448.58% | 1,448.58% | 1,448.58% |
News Based Sentiment: Genesis IBRC India vs Zota Health Care
Genesis IBRC India
News based Sentiment: POSITIVE
Genesis IBRC India Ltd. experienced a remarkably positive month, achieving new all-time highs and demonstrating exceptional growth across multiple timeframes. The company's strong financial performance, coupled with its zero debt status, significantly strengthens its investment appeal and positions it for continued success.
Zota Health Care
News based Sentiment: MIXED
September presented a mixed bag for Zota Health Care, with impressive revenue growth overshadowed by continued losses and a stock price decline. While the dividend and AGM were positive signals, the underlying profitability issues remain a significant concern for investors, making this a moderately important month for the company's investment story.
Performance & Financial Health Analysis: Genesis IBRC India vs Zota Health Care
| Metric | GENESIS | ZOTA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.03B | ₹46.71B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 1 | 58,098 |
| 90 Day Avg. Volume | 4 | 77,638 |
| Last Close | ₹78.98 | ₹1,540.00 |
| 52 Week Range | ₹15.85 - ₹78.98 | ₹535.00 - ₹1,555.00 |
| % from 52W High | 0.00% | -0.96% |
| All-Time High | ₹78.98 (Oct 03, 2025) | ₹1,555.00 (Sep 15, 2025) |
| % from All-Time High | 0.00% | -0.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | 0.84% |
| Quarterly Earnings Growth | N/A | 0.84% |
| Financial Health | ||
| Profit Margin (TTM) | 0.95% | -0.17% |
| Operating Margin (TTM) | 0.95% | -0.10% |
| Return on Equity (TTM) | 0.41% | -0.25% |
| Debt to Equity (MRQ) | 0.00 | 0.61 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹7.72 | ₹78.12 |
| Cash per Share (MRQ) | ₹0.00 | ₹0.73 |
| Operating Cash Flow (TTM) | ₹0 | ₹-1,007,999,000 |
| Levered Free Cash Flow (TTM) | ₹35.05M | ₹-563,984,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.07% |
| Last 12-Month Dividend | N/A | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Genesis IBRC India vs Zota Health Care
| Metric | GENESIS | ZOTA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 29.47 | -74.47 |
| Forward P/E | N/A | N/A |
| PEG Ratio | 1.03 | -29.79 |
| Price to Sales (TTM) | 28.00 | 13.44 |
| Price to Book (MRQ) | 10.23 | 19.30 |
| Market Capitalization | ||
| Market Capitalization | ₹1.03B | ₹46.71B |
| Enterprise Value | ₹1.04B | ₹48.09B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 28.26 | 16.41 |
| Enterprise to EBITDA | 29.57 | -1,139.61 |
| Risk & Other Metrics | ||
| Beta | 0.54 | 0.49 |
| Book Value per Share (MRQ) | ₹7.72 | ₹78.12 |
Financial Statements Comparison: Genesis IBRC India vs Zota Health Care
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | GENESIS | ZOTA |
|---|---|---|
| Revenue/Sales | ₹0 | ₹1.04B |
| Cost of Goods Sold | N/A | ₹451.33M |
| Gross Profit | N/A | ₹584.50M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-1.18M | ₹-107.17M |
| EBITDA | ₹-1.18M | ₹48.28M |
| Pre-Tax Income | ₹-1.18M | ₹-130.85M |
| Income Tax | ₹0 | ₹6.93M |
| Net Income (Profit) | ₹-1.18M | ₹-137.78M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | GENESIS | ZOTA |
|---|---|---|
| Cash & Equivalents | ₹57,000 | ₹21.32M |
| Total Current Assets | ₹88.35M | ₹1.84B |
| Total Current Liabilities | ₹3.03M | ₹1.01B |
| Long-Term Debt | N/A | ₹1.08B |
| Total Shareholders Equity | ₹85.33M | ₹2.27B |
| Retained Earnings | ₹-83.06M | ₹-191.89M |
| Property, Plant & Equipment | N/A | ₹65.25M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | GENESIS | ZOTA |
|---|---|---|
| Operating Cash Flow | N/A | ₹-8.57M |
| Capital Expenditures | N/A | ₹-982,011 |
| Free Cash Flow | N/A | ₹41.94M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | GENESIS | ZOTA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 1 | 58,098 |
| Average Daily Volume (90 Day) | 4 | 77,638 |
| Shares Outstanding | 13.00M | 28.64M |
| Float Shares | 577,640 | 12.58M |
| % Held by Insiders | 0.96% | 0.00% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Genesis IBRC India vs Zota Health Care
| Metric | GENESIS | ZOTA |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹1.00 |
| Last 12-Month Dividend Yield | N/A | 0.07% |
| 3-Year Avg Annual Dividend | N/A | ₹1.00 |
| 3-Year Avg Dividend Yield | N/A | 0.16% |
| 3-Year Total Dividends | N/A | ₹3.00 |
| Ex-Dividend Date | N/A | Sep 22, 2025 |